Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm. Inhibits further breakdown of the aneurysm by disrupting the “aortic degradation process”. Strengthens the...
Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm. Inhibits further breakdown of the aneurysm by disrupting the “aortic degradation process”. Strengthens the vessel wall by cross-linking within the tissue; this wall strengthening lowers the risk of rupture Our technology allows for earlier intervention in a much safer manner

List your booth number for exhibitions, ask us